Your browser is out of date

With an updated browser, you will have a better Medtronic website experience. Update my browser now.

×

Skip to main content

Endurant™ II

Alert Indications, Safety, and Warnings

Endurant™ II/IIs Stent Graft Systems for the treatment of Abdominal Aortic Aneurysm 

The Endurant™ family of products provides the standard of care with a legacy of clinical success for the treatment of abdominal aortic aneurysm (AAA). 

Contact Us
Endurant IIs stent graft on white background
Alert Indications, Safety, and Warnings

Overview

Only the Endurant™ family of products, designed to address sac regression,1 has the deep clinical experience, favorable outcomes, and the most validated data on any single graft for everyday or extraordinary challenges. For the past five years, the Endurant II/IIs has been used in 1 out of 3 EVAR cases,1 with use in more than 450,000 patients worldwide.1

The Endurant™ family

  • Includes Endurant™ II, Endurant™ IIs, and Endurant™ AUI stent grafts
  • Optimizes outcomes for the broadest patient base
  • Utilizes the Endurant™ II delivery system, which allows for accurate placement and controlled deployment

Endurant II, Endurant IIs, and Endurant II AUI on blue gradient background

Product features

Endurant™ IIs stent graft is a three-piece system that:

  • Leverages the proven design of the leading Endurant™ II abdominal stent graft
  • Expands anatomical customization options
  • Offers a shorter ipsilateral leg for more flexible, targeted limb placement
  • Features equal leg diameters to allow limbs to be used on either side
  • Utilizes the existing delivery system allowing accurate placement and controlled deployment
  • Provides up to a 20% reduction in distal diameter compared to select Endurant™ II bifurs
  • Enables in situ sizing with select ipsilateral limbs, allowing a 3–5 stent overlap for adjustment during case
  • Allows easier pre-case planning to simplify sizing
Endurant™ II stent graft deployment on blue background

Accurate placement and controlled deployment.2 Flexible, kink-resistant delivery system facilitates stent graft delivery. Tip capture for precise positioning adjustments, including adjustment of placement proximally or distally. 

Endurant™ II M-shape design features highlighted in blue box on a blue background

Continuous seal, fixation, and graft conformability.3 M-shaped proximal stents provide wall apposition and circumferential conformability.

Endurant™ II stent graft multifilament polyester graft material

Durable hemostatic barrier and resistance against type II endoleaks.4 High density, multifilament polyester graft material provides lower porosity for resistance against type II endoleaks.

Endurant™ II Delivery System controlled deployment

Deployment, capture, and release of the Endurant™ II stent.

  • The Endurant™ II delivery system helps ensure precise control and accurate placement at every stage of deployment, with 99.3% delivery and deployment success.*2
  • Tip capture delivery allows precise adjustment of position, proximally or distally, even after deployment of three stent rings. Control the release of the suprarenal stent and anchor pins with the back-end thumb wheel.

Deployment of the Endurant™ II Stent Graft

Deployment of the Endurant™ IIs Stent Graft

Manuals and technical guides

Instructions for use

Find this technical manual in the Medtronic Manual Library, in the product labeling supplied with each device.

Model specifications

pdf Endurant II/IIs Systems sizing sheet (.pdf)

Use this tool to plan case specifics such as sizing and placement.

215KB

Download sizing sheet
Document thumbnail

Ordering information

Endurant™ II Bifurcated Devices

  Proximal
Graft
Diameter
(mm)		 Distal
Graft
Diameter
(mm)		 Distal
Design		 Total
Covered
Length
(mm)		 Delivery
System		 Catheter
Outer
Diameter
(F)
ETBF  23 13 C 124 EE 18
ETBF  23 13 C 145 EE 18
ETBF  23 13 C 166 EE 18
ETBF  23 16 C 124 EE 18
ETBF  23 16 C 145 EE 18
ETBF  23 16 C 166 EE 18
ETBF  25 13 C 124 EE 18
ETBF  25 13 C 145 EE 18
ETBF  25 13 C 166 EE 18
ETBF  25 16 C 124 EE 18
ETBF  25 16 C 145 EE 18
ETBF  25 16 C 166 EE 18
ETBF  28 13 C 124 EE 18
ETBF  28 13 C 145 EE 18
ETBF  28 13 C 166 EE 18
ETBF  28 16 C 124 EE 18
ETBF  28 16 C 145 EE 18
ETBF  28 16 C 166 EE 18
ETBF  28 20 C 124 EE 18
ETBF  28 20 C 145 EE 18
ETBF  28 20 C 166 EE 18
ETBF  32 16 C 124 EE 20
ETBF  32 16 C 145 EE 20
ETBF  32 16 C 166 EE 20
ETBF  32 20 C 124 EE 20
ETBF  32 20 C 145 EE 20
ETBF  32 20 C 166 EE 20
ETBF  36 16 C 145 EE 20
ETBF  36 16 C 166 EE 20
ETBF  36 20 C 145 EE 20
ETBF  36 20 C 166 EE 20

Endurant™ IIs Bifurcated Devices

  Proximal
Graft
Diameter
(mm)		 Distal
Graft
Diameter
(mm)		 Distal
Design		 Total
Covered
Length
(mm)		 Delivery
System		 Catheter
Outer
Diameter
(F)
ESBF  23 14 C 103 EE 18
ESBF 25 14 C 103 EE 18
ESBF 28 14 C 103 EE 18
ESBF 32 14 C 103 EE 20
ESBF 36 14 C 103 EE 20

Limbs†

 

Distal

Graft
Diameter
(mm)

 Distal
Graft
Diameter
(mm)		 Distal
Design		 Total
Covered
Length
(mm)		 Delivery
System		 Catheter
Outer
Diameter
(F)		 Total
Contralateral
Covered
Length with
EII/EIIs
Bifurcated‡		 Total
Ipsilateral
Covered
Length with
EIIs
Bifurcated§
ETLW 16 10 C 82 EE 14 136 155
ETLW 16 10 C 93 EE 14 147 166
ETLW 16 10 C 124 EE 14 178 177–197
ETLW 16 10 C 146 EE 16 196 196-216
ETLW 16 10 C 156 EE 16 210 209–229
ETLW 16 10 C 199 EE 16 253 252–272
ETLW 16 13 C 82 EE 14 136 155
ETLW 16 13 C 93 EE 14 147 166
ETLW 16 13 C 124 EE 14 178 177–197
ETLW 16  10 C  146  EE  16  196  196-216 
ETLW 16 13 C 156 EE 16 210 209–229
ETLW 16 13 C 199 EE 16 253 252–272
ETLW 16 16 C 82 EE 14 136 135–155
ETLW 16 16 C 93 EE 14 147 146–166
ETLW 16 16 C 124 EE 14 178 177–197
ETLW 16 13  C  146  EE  16  196  196-216 
ETLW 16 16 C 156 EE 16 210 209–229
ETLW 16 16 C 199 EE 16 253 252–272
ETLW 16 20 C 82 EE 16 136 155
ETLW 16 20 C 93 EE 16 147 166
ETLW 16 20 C 124 EE 16 178 177–197
ETLW 16 16  C  146  EE  16  196  196-216 
ETLW 16 20 C 156 EE 16 210 209–229
ETLW 16 20 C 199 EE 16 253 252-272
ETLW 16 24 C 82 EE 16 136 155
ETLW 16 24 C 93 EE 16 147 166
ETLW 16 24 C 124 EE 16 178 177–197
ETLW 16 24  C  146  EE  16  196  196-216 
ETLW 16 24 C 156 EE 16 210 209–229
ETLW 16 24 C 199 EE 16 253 252–272
ETLW 16 28 C 82 EE 16 136 155
ETLW 16 28 C 93 EE 16 147 166
ETLW 16 28 C 124 EE 16 178 177–197
ETLW 16 28  C  146  EE  16  196  196-216
ETLW 16 28 C 156 EE 16 210 209–229
ETLW 16 28 C 199 EE 16 253 252–272
 

Aortic Extensions

 

Proximal
Graft
Diameter
(mm)

 Distal
Graft
Diameter
(mm)		 Distal
Design		 Total
Covered
Length
(mm)		 Delivery
System		 Catheter
Outer
Diameter
(F)
ETCF  23 23 C 49 EE 18
ETCF  25 25 C 49 EE 18
ETCF  28 28 C 49 EE 18
ETCF  32 32 C 49 EE 20
ETCF  36 36 C 49 EE 20 

Abdominal Tubes

  Proximal
Graft
Diameter
(mm)		 Distal
Graft
Diameter
(mm)		 Distal
Design		 Total
Covered
Length
(mm)		 Delivery
System		 Catheter
Outer
Diameter
(F)
ETTF 23 23 C 70 EE 18
ETTF 25 25 C 70 EE 18
ETTF 28 28 C 70 EE 18
ETTF 32 32 C 70 EE 20
ETTF 36 36 C 70 EE 20

Endurant™ II AUI

  Proximal
Graft
Diameter
(mm)		 Distal
Graft
Diameter
(mm)		 Distal
Design		 Total
Covered
Length
(mm)		 Delivery
System		 Catheter
Outer
Diameter
(F)
ETUF 23 14 C 102 EE 18
ETUF 25 14 C 102 EE 18
ETUF 28 14 C 102 EE 18
ETUF 32 14 C 102 EE 20
ETUF 36 14 C 102 EE 20

Iliac Extensions

  Proximal
Graft
Diameter
(mm)		 Distal
Graft
Diameter
(mm)		 Distal
Design		 Total
Covered
Length
(mm)		 Delivery
System		 Catheter
Outer
Diameter
(F)
ETEW  10 10 C 82 EE 14
ETEW  13 13 C 82 EE 14
ETEW  20 20 C 82 EE 16
ETEW  24 24 C 82 EE 16
ETEW  28 28 C 82 EE 18

     

Aortic catalog

Choose from a complete portfolio of market-leading aortic vascular therapies to treat aneurysm disease.

Download catalog

Request more information

Contact us
*

Delivery success = successful vascular access and delivery of the device to the intended anatomical treatment site. Deployment success = successful deployment of the device in the intended site and the successful removal of the delivery system. Endurant™ US IDE trial: Makaroun M. One-year outcomes of the U.S. regulatory trial of the Endurant™ stent graft system. 

†

The limb mates with the AUI stent graft on the ipsilateral side.

‡

These calculations assume the minimum 30 mm overlap between the bifurcated stent graft and the contralateral iliac limb per the Endurant II Stent Graft System Instructions for Use. When using the 124 mm length bifurcated stent graft, subtract 10 mm from Total Contralateral Covered Length with Bifurcated.

§

The 3–5 stent overlap is available only with select limbs. Please refer to the Instructions for Use for more information.

References

1

Data on file Medtronic.

2

Makaroun M Tuchek M, Massop D, et al. One-year outcomes of the US regulatory trial of the Endurant™ stent graft system. J Vasc Surg. September 2011;54(3):601–608. Endurant™ US IDE trial.

3

Based on internal test report DVR7245 Design Verification Report: Endurant Stent Graft System conducted January–July 2007. Bench test data may not be indicative of clinical performance.

4

Wakefield TW, Shulkin BL, Fellows EP, Petry NA, Spaulding SA, Stanley JC. Platelet reactivity in human aortic grafts: a prospective, randomized midterm study of platelet adherence and release products in Dacron and polytetrafluoroethylene conduits. J Vasc Surg. February 1989;9(2):234–243.

CE mark 2797